HANSOH PHARMAC. HD-00001 (3KY) — Net Asset Momentum
HANSOH PHARMAC. HD-00001 (3KY) recorded a net asset momentum of 23.3% as of December 2025, with net assets of €35.36 Billion EUR. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See what is HANSOH PHARMAC. HD-00001's book value for net asset value and shareholders' equity analysis.
YoY Momentum
Current Net Assets
Years of Data
Country
HANSOH PHARMAC. HD-00001 Net Asset Momentum (2021–2025)
This chart tracks HANSOH PHARMAC. HD-00001's year-over-year net asset growth across 5 annual reporting periods from 2021 to 2025. The most recent momentum reading is +23.3%, with net assets of €35.36 Billion EUR as of December 2025. Check HANSOH PHARMAC. HD-00001 (3KY) tangible equity ratio to evaluate the tangible quality of the company's equity base.
Annual Net Asset History for HANSOH PHARMAC. HD-00001 (2021–2025)
The table below shows the complete annual net asset history for HANSOH PHARMAC. HD-00001 from 2021 to 2025, covering 5 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and overall valuation, see HANSOH PHARMAC. HD-00001 (3KY) market capitalisation.
| Year | Net Assets (EUR) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | €35.36 Billion | €39.90 Billion | €4.54 Billion | ▲ +23.3% |
| 2024 | €28.68 Billion | €31.66 Billion | €2.98 Billion | ▲ +11.2% |
| 2023 | €25.79 Billion | €33.04 Billion | €7.24 Billion | ▲ +13.9% |
| 2022 | €22.65 Billion | €30.00 Billion | €7.35 Billion | ▲ +13.1% |
| 2021 | €20.03 Billion | €27.16 Billion | €7.13 Billion | — |